Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
TRV GP V, LLC (CIK 1990717) reported $498.2M across 3 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: RAPP ($261.7M, 52.53%), SEPN ($208.2M, 41.78%), MAZE ($28.4M, 5.69%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RAPP | RAPPORT THERAPEUTICS, INC. | $261.7M | 52.53% | 6.3M | Trimmed |
| 2 | SEPN | SEPTERNA, INC. | $208.2M | 41.78% | 6.2M | Hold |
| 3 | MAZE | MAZE THERAPEUTICS, INC. | $28.4M | 5.69% | 950,800 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30